Opto Circuits' US subsidiary launches next-gen patient monitor at German show - MEDICA 2009

Image
Announcement Corporate
Last Updated : Jan 20 2013 | 12:21 AM IST

Group’s other companies also showcase leading non invasive products at the Expo.

Opto Circuits India Limited and its subsidiaries – US-based Criticare Systems Inc. (CSI) and Mediaid Inc. are participating in The World Forum for Medicine, the MEDICA in Dusseldorf.  The focus of this year’s show is the global launch of CSI’s new patient monitor, the eVision™, a modular design featuring a 15 inch high resolution touch screen display with an interactive user interface. CSI is also showcasing its entire range of gas benches, multi-parameter monitors and SPO2 sensors in an extravagant display where even a new “pod” style meeting room was incorporated into this year’s booth design to hold private meetings with distributors and potential customers. CSI has sales and engineering personnel available at the booth.

Mediaid is also contributing to the Group’s presence in the show by displaying its range of desktop and handheld monitors.

The World Forum for Medicine, the MEDICA in Dusseldorf, counts over 4300 Exhibitors from 60 nations, a record participation. Innovations from the medical sector and medical research are presented.

About Opto Circuits (India) Ltd.
Opto Circuits (India) Ltd. (OCI) (BSE Code: 532391; NSE Symbol: OPTOCIRCUI) is a 100 percent EOU and a leading manufacturer of healthcare equipment in India. The product profile includes digital thermometers, sensors, pulse oximeters, patient monitoring systems, stents, catheters and other innovative products. In 2001, OCI acquired 60 per cent stake in Advanced Micronic Devices (AMDL) to market and distribute its products in India. Mediaid came into existence with the acquisition of the patient monitoring division of Palco Labs, US, in end-2003 and it now directly markets OCI’s products in the US. OCI acquired Eurocor GmbH in 2006. EuroCor manufactures Cardiac Stents of various types, including Drug Eluting Coronary stents. In April 2007, OCI ventured into new product segments - Urology, Gastroenterology, Gynecology and Orthopedics after acquiring Devon Innovations Private Limited (Bangalore) and Ormed Medical Technology Limited (Chennai). OCI completed the acquisition of US based Criticare Systems, Inc. in April 2008. Criticare designs, manufactures, and markets leading edge patient monitoring systems, vital signs monitors and gas benches for a wide range of hospitals and alternate health care environments throughout the world.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 20 2009 | 7:16 PM IST

Next Story